GR3027725T3 - Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions - Google Patents

Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions

Info

Publication number: GR3027725T3
Authority: GR; Greece
Prior art keywords: budesonide; medicament; operative conditions; enteral fluid; following post
Prior art date: 1993-11-24

Application number

GR980401905T

Other languages

English (en)

Inventor

Karl-Wilhelm Ecker

Original Assignee

Falk Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-24

Filing date

1998-08-26

Publication date

1998-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6503342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3027725(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-26 Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh

1998-11-30 Publication of GR3027725T3 publication Critical patent/GR3027725T3/el

Links

VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 2
229960004436 budesonide Drugs 0.000 title abstract 2
239000012530 fluid Substances 0.000 title abstract 2
230000002980 postoperative effect Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
230000000968 intestinal effect Effects 0.000 abstract 2
206010001367 Adrenal insufficiency Diseases 0.000 abstract 1
206010003694 Atrophy Diseases 0.000 abstract 1
206010012735 Diarrhoea Diseases 0.000 abstract 1
208000031886 HIV Infections Diseases 0.000 abstract 1
208000037357 HIV infectious disease Diseases 0.000 abstract 1
208000027207 Whipple disease Diseases 0.000 abstract 1
208000017515 adrenocortical insufficiency Diseases 0.000 abstract 1
230000037444 atrophy Effects 0.000 abstract 1
208000037902 enteropathy Diseases 0.000 abstract 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
208000028774 intestinal disease Diseases 0.000 abstract 1
210000004400 mucous membrane Anatomy 0.000 abstract 1
238000002271 resection Methods 0.000 abstract 1
206010044697 tropical sprue Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GR980401905T 1993-11-24 1998-08-26 Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions GR3027725T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4340057A DE4340057A1 (de)	1993-11-24	1993-11-24	Budesonid-Arzneimittel zur Verbesserung der enteralen Flüssigkeitsresorption, insbesondere nach postoperativen Zuständen
PCT/EP1994/003165 WO1995014474A1 (de)	1993-11-24	1994-09-22	Budesonid-arzneimittel zur verbesserung der enteralen flüssigkeitsresorption, insbesondere nach postoperativen zuständen

Publications (1)

Publication Number	Publication Date
GR3027725T3 true GR3027725T3 (en)	1998-11-30

Family

ID=6503342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR980401905T GR3027725T3 (en)	1993-11-24	1998-08-26	Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions

Country Status (7)

Country	Link
EP (1)	EP0725644B1 (el)
AT (1)	ATE169220T1 (el)
DE (2)	DE4340057A1 (el)
DK (1)	DK0725644T3 (el)
ES (1)	ES2120068T3 (el)
GR (1)	GR3027725T3 (el)
WO (1)	WO1995014474A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4446891A1 (de) *	1994-12-27	1996-07-04	Falk Pharma Gmbh	Stabile wäßrige Budesonid-Lösung
IL122752A (en)	1995-06-27	2001-07-24	Boehringer Ingelheim Kg	Stable preparations for creating propellant-free sprays
US5863910A (en) *	1996-01-12	1999-01-26	Bolonick; Joel	Treatment of chronic inflammatory disorders of the gastrointestinal tract
EP3613414A1 (de) *	2018-08-24	2020-02-26	Dr. Falk Pharma Gmbh	Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2113221C1 (ru) *	1990-05-04	1998-06-20	Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим	Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы

1993
- 1993-11-24 DE DE4340057A patent/DE4340057A1/de not_active Withdrawn
1994
- 1994-09-22 DE DE59406625T patent/DE59406625D1/de not_active Revoked
- 1994-09-22 EP EP94928390A patent/EP0725644B1/de not_active Revoked
- 1994-09-22 ES ES94928390T patent/ES2120068T3/es not_active Expired - Lifetime
- 1994-09-22 AT AT94928390T patent/ATE169220T1/de not_active IP Right Cessation
- 1994-09-22 DK DK94928390T patent/DK0725644T3/da active
- 1994-09-22 WO PCT/EP1994/003165 patent/WO1995014474A1/de not_active Ceased
1998
- 1998-08-26 GR GR980401905T patent/GR3027725T3/el unknown

Also Published As

Publication number	Publication date
ATE169220T1 (de)	1998-08-15
EP0725644A1 (de)	1996-08-14
DK0725644T3 (da)	1999-02-08
ES2120068T3 (es)	1998-10-16
EP0725644B1 (de)	1998-08-05
WO1995014474A1 (de)	1995-06-01
DE4340057A1 (de)	1995-06-01
DE59406625D1 (de)	1998-09-10

Similar Documents

Publication	Publication Date	Title
BG101118A (en)	1998-04-30	Therapeutical compounds
BR0013771A (pt)	2002-05-14	Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
EP1210941A3 (en)	2002-07-31	Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS
MXPA04012965A (es)	2005-05-16	Inhibidores virales.
ATE337786T1 (de)	2006-09-15	Verwendung von taurolidine oder taurultam zur behandlung und prävention von infektionen in medizinischen freisetzungssystemen
NO302574B1 (no)	1998-03-23	Indolkarbazolimider og deres anvendelse
IL113941A (en)	2000-02-17	Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
ES2153851T3 (es)	2001-03-16	Tratamiento de la atrofia de la piel y de la vagina.
HU9603042D0 (en)	1997-01-28	Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
AU1794601A (en)	2001-06-04	Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
ZA991029B (en)	1999-09-30	Composition and methods for treatment of hiv infections.
WO1996022305A3 (en)	1996-09-06	Modified peptides
MX9708611A (es)	1998-02-28	Compuestos de dialquiltiacumicina.
GR3027725T3 (en)	1998-11-30	Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions
CA2100066A1 (en)	1992-10-13	Michellamines useful as antiviral agents, composition and method of treatment
AP9400647A0 (en)	1995-11-20	Medicaments for use in treatment of HIV or cancer patients.
MD970254A (en)	1999-05-31	Use of melatonine for treatment of patients having a medicamental dependence
BG102404A (en)	1998-12-30	The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
PL307864A1 (en)	1995-06-26	Retroviral infection inhibition
UA42693C2 (uk)	2001-11-15	Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
AU2396900A (en)	2000-07-31	Treatment and prevention of hiv and other viral infections
KR970704441A (ko)	1997-09-06	사람 면역결핍증 바이러스 프로테아제 억제제 배합물(HIV Protease inhibitor combination)
DE60305018D1 (de)	2006-06-08	Citalopram zur behandlung von bluthochdruck
IL115585A0 (en)	1996-01-19	Dipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them